Are you one of those interested in self-help books?
If you are, I suggest you go through Atomic Habits by James Clear. It provides a very practical and effective way of making small improvements in your daily life through habits.
It talks about getting 1% better every day.
Over time, these small 1% improvements grow into big results.
I believe this is true in the investing world as well.
Why do I say that?
You see, India too is improving 1% every day. That's why it's difficult to notice the improvement.
But the improvement is real and will likely change the face of our country for the better in the decade ahead.
Just look at India's current population demographic. More than 65% of the population is below the age of 35.
Some people may talk about the problem of creating jobs for so many people entering the workforce.
On the other hand, it is a great opportunity if utilised in the right manner.
We saw this in the early 90s with outsourcing in the IT industry.
India had a huge English-speaking population. As a result, we became the preferred destination for IT-BPM (Business Process Management) services.
This industry now employs close to 3.9 million of the working population. And adds close to 0.1 million people annually.
But there's another sector in which I see a similar trend - Pharma.
Let me tell you about it...
The traditional model for pharma companies in developed countries was to focus on drug discovery via their in-house Research and Development (R&D).
This was fine with patents running for over 15-20 years. This was long enough to cover their R&D costs.
But the past few years has seen a faster pace for drug approvals for generic drugs.
As per the US Food and Drug Administration (USFDA), 763 drug approvals were received in FY17 as compared to 440 in FY13.
With more generic drugs hitting the market, at a faster pace, the days of milking patents for decades is over.
To counter this, big pharma companies are looking for cost effective measures to reduce their R&D spend.
Did you know that India ranks 4th in the world among countries with the most doctoral graduates?
For a big pharma company, the cost per scientist, for R&D in India, is 3.5 times lower than the in-house cost.
Contract Research Organisations (CROs) are the companies in India providing research services to big pharma companies.
This is a classic example of India's huge working population presenting a great opportunity for investors like yourself.
And this is just one irreversible trend... I've identified 50 such irreversible trends in the economy today.
I'm not talking about the distant future. These trends are happening right now in India!
Like 1% improvements, not everyone will spot them... But the investor who catches these trends early, will create life-changing wealth for himself.
These irreversible trends have the potential to snowball into a huge transformation.
This transformation is what I call - Rebirth of India.
The Rebirth of India is at the heart of my big prediction: Sensex 100,000.
I'm not talking about stocks that could go up 2 or 3 times. I'm talking about huge multibagger returns that could change your life forever.
As I've written to you over the last few days, the Rebirth of India is a once in a lifetime opportunity.
You need to make sure that you don't miss out on this, dear reader.
I recommend you download and read this free report - Rebirth of India. I prepared this special report to show you how you can benefit from this historic opportunity.
Also, don't forget to join me for the Rebirth of India summit on Thursday, 31 January. I'll explain the opportunity in detail at the summit.
Registration is open and it's free.
I hope to see you there!
| --- Advertisement ---
4 Stocks Flashing a "BUY" Right Now
While most stock analysts do all their research from a stuffy office, the editor of our small cap service, Richa Agarwal, goes the extra mile...
She's travels hundreds of thousands of kilometres in search of new investment ideas for Equitymaster subscribers.
This is one of the reasons Richa's recommendations from Hidden Treasure have generated double, triple and even four-digit gains in the long run.
And her 'boots-on-the-ground' research has recently uncovered 4 lesser-known small companies you could consider investing in right now.
Click here to know about these 4 companies now…
Chart of the Day
Speaking of talent in India, did you know that higher education is no more the domain of developed economies?
According to the latest Organisation for Economic Co-operation and Development (OECD) report, India ranks 4th in the number of doctoral graduates worldwide.
Will India Be the World's Biggest Talent Hub?
United States tops the list followed by Germany, United Kingdom, and India.
Growth rates of graduates among developed nations are showing signs of a slowdown. Lack of interest in science as well as an ageing population are one of the main reasons for this.
On the other hand, India with its young population has no such issues. Scarcity of talent means these developed nations will have to rely on talent from emerging nations like India.
Indian companies that can train and retain highly skilled talent will benefit from this irreversible trend.
And there are 50 such irreversible trends driving the Rebirth of India.
Tanushree Banerjee (Research Analyst)
Editor, The 5 Minute WrapUp
PS: We have just published - Rebirth of India: The First Step to the Biggest Investment Opportunity of Your Lifetime. I strongly urge you to download it and read it right away. It has the potential to dramatically change your life for the better. When you download it, you will automatically get a seat at the Rebirth of India MEGA SUMMIT where Tanushree will reveal full details about the Rebirth of India.
Copyright © Equitymaster Agora Research Private Limited. All rights reserved.
Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringementDisclosure & Disclaimer:
Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. The Author does not hold any shares in the company/ies discussed in this document. Equitymaster may hold shares in the company/ies discussed in this document under any of its other services.
This document is confidential and is supplied to you for information purposes only. It should not (directly or indirectly) be reproduced, further distributed to any person or published, in whole or in part, for any purpose whatsoever, without the consent of Equitymaster.
This document is not directed to, or intended for display, downloading, printing, reproducing or for distribution to or use by, any person or entity, who is a citizen or resident or located in any locality, state, country or other jurisdiction, where such distribution, publication, reproduction, availability or use would be contrary to law or regulation or what would subject Equitymaster or its affiliates to any registration or licensing requirement within such jurisdiction. If this document is sent or has reached any individual in such country, especially, USA, Canada or the European Union countries, the same may be ignored.
This document does not constitute a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Our research recommendations are general in nature and available electronically to all kind of subscribers irrespective of subscribers' investment objectives and financial situation/risk profile. Before acting on any recommendation in this document, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek professional advice. The price and value of the securities referred to in this material and the income from them may go down as well as up, and subscribers may realize losses on any investments. Past performance is not a guide for future performance, future returns are not guaranteed and a loss of original capital may occur. Information herein is believed to be reliable but Equitymaster and its affiliates do not warrant its completeness or accuracy. The views/opinions expressed are our current opinions as of the date appearing in the material and may be subject to change from time to time without notice. This document should not be construed as an offer to sell or solicitation of an offer to buy any security or asset in any jurisdiction. Equitymaster and its affiliates, its directors, analyst and employees will not be responsible for any loss or liability incurred to any person as a consequence of his or any other person on his behalf taking any decisions based on this document.
As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use
, available here. The performance data quoted represents past performance and does not guarantee future results.SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.
Equitymaster Agora Research Private Limited (Research Analyst) 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: email@example.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407